98 related articles for article (PubMed ID: 15207260)
1. Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model.
Delatour B; Blanchard V; Pradier L; Duyckaerts C
Neurobiol Dis; 2004 Jun; 16(1):41-7. PubMed ID: 15207260
[TBL] [Abstract][Full Text] [Related]
2. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
3. Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging.
Woodhouse A; Vickers JC; Adlard PA; Dickson TC
Neurobiol Aging; 2009 Jun; 30(6):864-74. PubMed ID: 17950493
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
5. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
6. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
Rodrigo J; Fernández-Vizarra P; Castro-Blanco S; Bentura ML; Nieto M; Gómez-Isla T; Martínez-Murillo R; MartInez A; Serrano J; Fernández AP
Neuroscience; 2004; 128(1):73-89. PubMed ID: 15450355
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
9. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
10. The amyloid pathology progresses in a neurotransmitter-specific manner.
Bell KF; Ducatenzeiler A; Ribeiro-da-Silva A; Duff K; Bennett DA; Cuello AC
Neurobiol Aging; 2006 Nov; 27(11):1644-57. PubMed ID: 16271419
[TBL] [Abstract][Full Text] [Related]
11. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
12. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
[TBL] [Abstract][Full Text] [Related]
13. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.
Stoltenberg M; Bush AI; Bach G; Smidt K; Larsen A; Rungby J; Lund S; Doering P; Danscher G
Neuroscience; 2007 Dec; 150(2):357-69. PubMed ID: 17949919
[TBL] [Abstract][Full Text] [Related]
14. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
15. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging.
Braakman N; Matysik J; van Duinen SG; Verbeek F; Schliebs R; de Groot HJ; Alia A
J Magn Reson Imaging; 2006 Sep; 24(3):530-6. PubMed ID: 16892201
[TBL] [Abstract][Full Text] [Related]
17. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.
Boncristiano S; Calhoun ME; Howard V; Bondolfi L; Kaeser SA; Wiederhold KH; Staufenbiel M; Jucker M
Neurobiol Aging; 2005 May; 26(5):607-13. PubMed ID: 15708435
[TBL] [Abstract][Full Text] [Related]
18. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
[TBL] [Abstract][Full Text] [Related]
19. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease.
Thomas P; Wang YJ; Zhong JH; Kosaraju S; O'Callaghan NJ; Zhou XF; Fenech M
Mutat Res; 2009 Feb; 661(1-2):25-34. PubMed ID: 19027755
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent axonal degeneration in an Alzheimer mouse model.
Wirths O; Weis J; Kayed R; Saido TC; Bayer TA
Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
